Pioglitazone in pulmonary alveolar proteinosis: promising first clinical experience. - Suppr | 超能文献

相似文献

1

Pioglitazone in pulmonary alveolar proteinosis: promising first clinical experience.

Respir Med Res. 2020 Nov;78:100756. doi: 10.1016/j.resmer.2020.100756. Epub 2020 Apr 18.

2

Reduction in Alveolar Macrophage Size in Refractory Autoimmune Pulmonary Alveolar Proteinosis After Treatment With Pioglitazone.

J Bronchology Interv Pulmonol. 2020 Jul;27(3):219-222. doi: 10.1097/LBR.0000000000000686.

3

[Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis].[肺泡蛋白沉积症患者对吸入粒细胞巨噬细胞集落刺激因子的反应]

Arch Bronconeumol. 2009 Mar;45(3):150-2. doi: 10.1016/j.arbres.2008.02.006. Epub 2009 Feb 10.

4

[Therapeutic efficacy of GM-CSF in pulmonary alveolar proteinosis].[粒细胞巨噬细胞集落刺激因子治疗肺泡蛋白沉积症的疗效]

Arch Bronconeumol. 2002 Apr;38(4):191-3. doi: 10.1016/s0300-2896(02)75188-0.

5

Rituximab therapy in autoimmune pulmonary alveolar proteinosis.利妥昔单抗治疗自身免疫性肺泡蛋白沉积症。

Eur Respir J. 2009 Jun;33(6):1503-6. doi: 10.1183/09031936.00160908.

6

Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.吸入 GM-CSF 治疗肺泡蛋白沉积症。

N Engl J Med. 2019 Sep 5;381(10):923-932. doi: 10.1056/NEJMoa1816216.

7

Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy.肺泡蛋白沉积症：对粒细胞-巨噬细胞集落刺激因子治疗的完全缓解。

Thorax. 2001 Aug;56(8):664-5. doi: 10.1136/thorax.56.8.664.

8

GM-CSF therapy in pulmonary alveolar proteinosis.粒细胞-巨噬细胞集落刺激因子治疗肺泡蛋白沉积症。

Thorax. 2002 Sep;57(9):837. doi: 10.1136/thorax.57.9.837.

9

Pulmonary alveolar proteinosis: time to shift?肺泡蛋白沉积症：是时候做出改变了吗？

Expert Rev Respir Med. 2015 Jun;9(3):337-49. doi: 10.1586/17476348.2015.1035259. Epub 2015 Apr 12.

10

Pulmonary alveolar proteinosis. What is the role of GM-CSF in disease pathogenesis and treatment?

Treat Respir Med. 2004;3(4):229-34. doi: 10.2165/00151829-200403040-00003.

引用本文的文献

1

Pharmacotherapy for Autoimmune Pulmonary Alveolar Proteinosis.自身免疫性肺泡蛋白沉积症的药物治疗

Drugs. 2025 Aug 27. doi: 10.1007/s40265-025-02228-3.

2

Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis.以发病机制为导向的原发性肺泡蛋白沉积症治疗。

Eur Respir Rev. 2024 Aug 14;33(173). doi: 10.1183/16000617.0064-2024. Print 2024 Jul.

3

Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies.肺泡蛋白沉积症中的肺泡巨噬细胞：起源、功能和治疗策略。